MY135477A
(en )
2008-04-30
2-(2,6-dichlorophenyl)-diarylimidazoles
PH12013500123A1
(en )
2015-10-26
Hemiasterlin derivatives and uses thereof
MY136095A
(en )
2008-08-29
Use of human anti-ctla-4 antibodies for treatment of cancer
MXPA03011197A
(en )
2004-02-26
Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents.
AU2002340168A1
(en )
2003-06-17
Treatment of prostate cancer by inhibitors of ncam2
IL146125A0
(en )
2002-07-25
Novel quinones as disease therapies
IL153680A0
(en )
2003-07-06
Aplidine derivatives and methods for the preparation thereof
BR9912327A
(en )
2001-05-02
Urokinase inhibitors
HUP0500424A2
(en )
2007-02-28
Combination therapy for the treatment of cancer
AU2002367172A1
(en )
2003-07-15
2,4-diamino-pyrimidine derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
PL375527A1
(en )
2005-11-28
Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases
GB2378948B
(en )
2004-11-10
Novel compounds for modulating cell proliferation
TR200002203T2
(en )
2000-12-21
Treatment of follicular lymphomas using inhibitors of the lysophoxin (LT) expression pathway.
HUP0402341A3
(en )
2005-11-28
Compositions containing thiazol-2-ylamines for the treatment of cancer
MXPA02001204A
(en )
2004-05-21
Calcilytic compounds.
ZA200207260B
(en )
2003-09-10
Exemestane for first-line treatment of breast cancer.
PL357179A1
(en )
2004-07-26
Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers
WO2002020000A3
(en )
2003-02-27
Combined estrogen blockade of the breast with exemestane and raloxifene
BRPI0415355A
(en )
2006-12-12
triarylimidazoles
HUP0300772A3
(en )
2005-11-28
Medicament for the immunotherapy of malignant tumours
UA49216A
(en )
2002-09-16
Remedy for treating complication following resection of malignant tumors of skin
AU2003236701A8
(en )
2003-12-22
Guanidino phenylalanin compounds used as urokinase inhibitors
AU2001256440A1
(en )
2001-11-12
Medicines for treating tumoral pathologies containing the ro5-4864 compound and an apoptosis-inducing agent
IL150978A0
(en )
2003-02-12
Nitroacridine/tumor inhibitor compositions
DE60220504D1
(en )
2007-07-19
Tryptasehemmer